Health Condition 1: K928- Other specified diseases of the digestive system
Conditions
Interventions
None listed
Sponsors
Himalayiya Ayurvedic Medical College and Hospital Dehradun
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients willing to participate in the study. 2.Patients irrespective of sex, religion, occupation will be selected for study with age between 18-70 years. 3.Patients having sign and symptoms of Grahani Dosha and who are diagnosed with IBS according to standard ROME IIIrd criteria. 4.Previously diagnosed case of IBS
Exclusion criteria
Exclusion criteria: 1.Patients not willing to participate in the study. 2.Patients of either sex below 18 years & above 70 years will be excluded from the study. 3.Ulcerative colitis, Crohnâ??s disease, gastric ulcerations and other inflammatory bowel conditions, Parasitic infestation 4.Amoebic dysentery, acute diarrhoea, bleeding per rectum 5.Patients on prolonged medication with NSAIDs, analgesics or any other drugs that may have an influence on the outcome of the study 6.Alcoholic and/or drug abusers. 7.History of hypersensitivity to the trail drugs or any of its ingredients. 8.Pregnant /lactating woman. 9.Patients who have completed participation in any other clinical trial during the past 6 months. 10.Patents with diabetes mellitus, poorly controlled hypertension, Thyroid disorders and any other autoimmune disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To study in detail about IBS and its probable correlation in Ayurveda 2.To assess the efficacy of trial herbal compound in the treatment of IBSTimepoint: 15 days and 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Improvement in clinical features as per Assessment criteria(Sign and symptoms as per Ayurveda and IBS-SYMPTOM SEVERITY SCALE (IBS-SSS) ,IBS QOL-For Quality of Life ,BRISTOL STOOL SCALE-For consistency of stool ,OTHER SYMPTOMS (Frequency of stool, incomplete evacuation of stool,abdominal pain by VAS-scale, presence of mucus in stool, abdominal distention by VAS-scale) Timepoint: 15 days and 30 days during course of treatment | — |
Countries
India
Contacts
Public ContactDr Nitin Pandey
Gurukul Campus UAU Haridwar
Outcome results
None listed